| VSMAX | WESCX | VSMAX / WESCX | |
| Total Expense Ratio | 0.05 | 1.25 | 4% |
| Annual Report Gross Expense Ratio | 0.05 | 1.66 | 3% |
| Fund Existence | 26 years | 29 years | - |
| Gain YTD | 14.588 | 28.848 | 51% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 3000 | 1000 | 300% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 189B | 160M | 118,125% |
| Annual Yield % from dividends | 1.21 | 0.47 | 260% |
| Returns for 1 year | 22.58 | 44.72 | 50% |
| Returns for 3 years | 43.42 | 28.34 | 153% |
| Returns for 5 years | 35.11 | 25.35 | 138% |
| Returns for 10 years | 155.96 | 81.22 | 192% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BQLCX | 23.42 | 0.17 | +0.73% |
| Bright Rock Quality Large Cap Instl | |||
| GSPQX | 20.02 | 0.12 | +0.60% |
| Goldman Sachs US Eq Div and Premium C | |||
| GSIYX | 24.29 | N/A | N/A |
| Goldman Sachs GQG Ptnrs Intl Opps R6 | |||
| CCWIX | 21.73 | -0.15 | -0.69% |
| Baird Chautauqua International Gr Instl | |||
| RYOAX | 66.89 | -1.55 | -2.26% |
| Rydex Biotechnology H | |||